Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Figure S11 from Transient EZH2 Suppression by Tazemetostat during In Vitro Expansion Maintains T-Cell Stemness and Improves Adoptive T-Cell Therapy
Home
Publications
Figure S11 from Transient EZH2 Suppression by Tazemetostat during In Vitro Expansion Maintains T-Cell Stemness and Improves Adoptive T-Cell Therapy
Figure S11 from Transient EZH2 Suppression by Tazemetostat during In Vitro Expansion Maintains T-Cell Stemness and Improves Adoptive T-Cell Therapy
Authors:
YH
Yingqin Hou
Yingqin Hou
JZ
Jaroslav Zak
Jaroslav Zak
YS
Yujie Shi
Yujie Shi
IP
Isaraphorn Pratumchai
Isaraphorn Pratumchai
BD
Brandon Dinner
Brandon Dinner
WW
Wenjian Wang
Wenjian Wang
KQ
Ke Qin
Ke Qin
EW
Evan W. Weber
Evan W. Weber
JT
John R. Teijaro
John R. Teijaro
PW
Peng Wu
Peng Wu
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Download PDF
Download
Open Access
Publisher website
Google Scholar
17 June 2026
other
Published by
American Association for Cancer Research (AACR)
DOI:
10.1158/2326-6066.32698819
Abstract
Figure S11 Overlap of transcriptomic impact of Ezh2 deletion vs Taz treatment on CD8 T Cells.
Keywords
IMMUNOLOGY
T CELL EXHAUSTION
TUMOR IMMUNOLOGY ANIMAL MODELS
IMMUNOTHERAPY
ENGINEERED/CAR T CELLS
Related articles
Scroll to top